| PTC THERAPEUTICS DL-,001 |
| USA |
| Gesundheit |
| US69366J2006 / A1W0MW |
| BH3 (Frankfurt) / PTCT (NASDAQ) |
| FRA:BH3, ETR:BH3, BH3:GR, NASDAQ:PTCT |
| - |
| https://www.ptcbio.com/ |
|
Ptc Therapeutics Inc. is a biopharmaceutical compa..
>Volltext.. |
| 5979.33 Mio. EUR |
| 4889.25 Mio. EUR |
| 1536.22 Mio. EUR |
| 824.55 Mio. EUR |
| 649.08 Mio. EUR |
| 8.3 EUR |
| 354.13 Mio. EUR |
| 580.78 Mio. EUR |
| 617.77 Mio. EUR |
| 1.95 |
| 87.43% |
| - |
| - |
| - |
| - |
| 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 13.629.766 USD. |
| PTC THERAPEUTICS, PTC THERAPEUTIC, PTC THERA |
| 27.11.25 |